Faster‐acting insulin aspart versus insulin aspart for adults with type 1 diabetes treated with non‐automated insulin pump and continuous glucose monitoring—A double‐blind randomized controlled crossover trial
Faster aspart improved baseline-adjusted TIR, TAR, CV and HbA1c after 16 weeks with frequent insulin pump adjustments but had a higher incidence of injection site reactions.
Authors
- Signe Schmidt (ORCID: https://orcid.org/0000-0002-6968-6675)
- Kirsten Nørgaard (ORCID: https://orcid.org/0000-0003-1620-8271)
- Ajenthen G. Ranjan (ORCID: https://orcid.org/0000-0002-2253-6071)
Institutions
- University of Copenhagen (DK)
- Steno Diabetes Centers (DK)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2025-03-24
- DOI
- https://doi.org/10.1111/dom.16326
- Primary Topic
- Diabetes Management and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00